• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

间充质干细胞治疗下肢静脉溃疡:一种引人注目的疗法。

Mesenchymal stem cell in venous leg ulcer: An intoxicating therapy.

作者信息

Athanerey Anjali, Patra Pradeep Kumar, Kumar Awanish

机构信息

Department of Biotechnology, National Institute of Technology Raipur, Chhattisgarh, India.

Department of Biochemistry, Pt. JNM Medical College, Raipur, Chhattisgarh, India.

出版信息

J Tissue Viability. 2017 Aug;26(3):216-223. doi: 10.1016/j.jtv.2017.06.001. Epub 2017 Jun 7.

DOI:10.1016/j.jtv.2017.06.001
PMID:28619238
Abstract

Venous leg ulcers (VLU) are a prevalent and reoccurring type of complicated wound, turning as a considerable public healthcare issue, with critical social and economic concern. There are both medical and surgical therapies to treat venous leg ulcers; however, a cure does not yet exist. Mesenchymal stem cells (MSC) are capable and proved of accelerating wound healing in vivo and their study with human chronic wounds is currently awaited. MSCs are a promising source of adult progenitor cells for cellular therapy and have been demonstrated to differentiate into various mesenchymal cell lineages. They have a crucial and integral role in native wound healing by regulating immune response and inflammation. Improved understanding of the cellular and molecular mechanisms at work in delayed wound healing compels to the development of cellular therapy in VLU. This review focuses on the current treatment option of VLU and further emphasizing the role of MSCs in accelerating the healing process. With further understanding of the mechanism of action of these cells in wound improvement and, the involvement of cytokines can also be revealed that could be used for the therapeutic purpose for VLU healing. Clinical uses of MSCs have been started already, and induced MSCs are surely a promising tool or compelling therapy for VLU.

摘要

下肢静脉溃疡(VLU)是一种常见且易复发的复杂伤口,已成为一个重大的公共卫生问题,引起了社会和经济方面的严重关注。治疗下肢静脉溃疡有医学和外科两种疗法;然而,目前尚无治愈方法。间充质干细胞(MSC)已被证明能够在体内加速伤口愈合,目前人们正期待着对其在人类慢性伤口方面的研究结果。间充质干细胞是细胞治疗中很有前景的成体祖细胞来源,并且已被证明可分化为各种间充质细胞谱系。它们通过调节免疫反应和炎症在天然伤口愈合中发挥着关键且不可或缺的作用。对延迟伤口愈合中细胞和分子机制的深入了解促使人们在下肢静脉溃疡中开展细胞治疗。本综述重点关注下肢静脉溃疡的当前治疗选择,并进一步强调间充质干细胞在加速愈合过程中的作用。随着对这些细胞在伤口改善中作用机制的进一步了解,还可揭示细胞因子的参与情况,这些细胞因子可用于下肢静脉溃疡愈合的治疗目的。间充质干细胞的临床应用已经开始,诱导间充质干细胞肯定是治疗下肢静脉溃疡的一种有前景的工具或令人信服的疗法。

相似文献

1
Mesenchymal stem cell in venous leg ulcer: An intoxicating therapy.间充质干细胞治疗下肢静脉溃疡:一种引人注目的疗法。
J Tissue Viability. 2017 Aug;26(3):216-223. doi: 10.1016/j.jtv.2017.06.001. Epub 2017 Jun 7.
2
Pathophysiology of wound healing and alterations in venous leg ulcers-review.腿部静脉溃疡伤口愈合的病理生理学及改变——综述
Phlebology. 2016 Mar;31(1 Suppl):56-62. doi: 10.1177/0268355516632998.
3
Prognostic factors associated with healing of venous leg ulcers: a multicentre, prospective, cohort study.与静脉性腿部溃疡愈合相关的预后因素:一项多中心、前瞻性队列研究。
Br J Dermatol. 2013 Nov;169(5):1106-13. doi: 10.1111/bjd.12570.
4
Venous leg ulcers: Impact and dysfunction of the venous system.下肢静脉溃疡:静脉系统的影响与功能障碍
J Vasc Nurs. 2015 Jun;33(2):54-9. doi: 10.1016/j.jvn.2015.01.002.
5
A randomized, controlled, double-blind prospective trial with a Lipido-Colloid Technology-Nano-OligoSaccharide Factor wound dressing in the local management of venous leg ulcers.一项采用脂质体胶体技术-纳米寡糖因子创面敷料局部治疗静脉性腿部溃疡的随机、对照、双盲前瞻性试验。
Wound Repair Regen. 2012 Jul-Aug;20(4):500-11. doi: 10.1111/j.1524-475X.2012.00797.x. Epub 2012 Jun 8.
6
Antiseptic with modern wound dressings in the treatment of venous leg ulcers: clinical and microbiological aspects.防腐剂联合现代伤口敷料治疗下肢静脉溃疡:临床及微生物学方面
J Wound Care. 2016 Aug;25(8):419-26. doi: 10.12968/jowc.2016.25.8.419.
7
Topical Delivery of Mesenchymal Stem Cells "Secretomes" in Wound Repair.间充质干细胞“分泌组”在伤口修复中的局部递送
Acta Med Indones. 2016 Jul;48(3):217-220.
8
Chronic venous disease - Part II: Proteolytic biomarkers in wound healing.慢性静脉疾病 - 第二部分:伤口愈合中的蛋白水解生物标志物
Biochim Biophys Acta. 2016 Oct;1862(10):1900-8. doi: 10.1016/j.bbadis.2016.07.011. Epub 2016 Jul 25.
9
Risk factors related to the failure of venous leg ulcers to heal with compression treatment.与腿部静脉溃疡在压迫治疗下无法愈合相关的危险因素。
J Vasc Surg. 2009 May;49(5):1242-7. doi: 10.1016/j.jvs.2008.11.069. Epub 2009 Feb 23.
10
[Cellular therapy and leg ulcers: Future approaches].[细胞疗法与腿部溃疡:未来的方法]
Ann Dermatol Venereol. 2015 Aug-Sep;142(8-9):519-22. doi: 10.1016/j.annder.2015.06.010. Epub 2015 Jul 15.

引用本文的文献

1
Application of allogeneic adult mesenchymal stem cells in the treatment of venous ulcers: A phase I/II randomized controlled trial protocol.异体成人间充质干细胞在静脉溃疡治疗中的应用:一项I/II期随机对照试验方案。
PLoS One. 2025 May 15;20(5):e0323173. doi: 10.1371/journal.pone.0323173. eCollection 2025.
2
Mesenchymal Stem Cell-Derived Extracellular Vesicles as an Advanced Therapy for Chronic Wounds.间充质干细胞衍生的细胞外囊泡作为慢性伤口的一种先进疗法。
Cold Spring Harb Perspect Biol. 2022 Oct 3;14(10):a041227. doi: 10.1101/cshperspect.a041227.
3
[Mesenchymal stem cells and skin injury repair].
[间充质干细胞与皮肤损伤修复]
Sheng Wu Yi Xue Gong Cheng Xue Za Zhi. 2021 Apr 25;38(2):387-392. doi: 10.7507/1001-5515.202011017.
4
Strategies and challenges in the treatment of chronic venous leg ulcers.下肢慢性静脉溃疡治疗中的策略与挑战
World J Clin Cases. 2020 Nov 6;8(21):5070-5085. doi: 10.12998/wjcc.v8.i21.5070.
5
Autologous platelet-rich plasma injection enhances healing of chronic venous leg ulcer: A prospective randomised study.富血小板血浆注射促进慢性静脉性腿部溃疡的愈合:一项前瞻性随机研究。
Int Wound J. 2020 Aug;17(4):992-1001. doi: 10.1111/iwj.13361. Epub 2020 Apr 13.
6
Can supernatant from immortalized adipose tissue MSC replace cell therapy? An in vitro study in chronic wounds model.永生化脂肪组织 MSC 的上清液能否替代细胞治疗?慢性创面模型的体外研究。
Stem Cell Res Ther. 2020 Jan 21;11(1):29. doi: 10.1186/s13287-020-1558-5.
7
Current Therapeutic Strategies for Stem Cell-Based Cartilage Regeneration.基于干细胞的软骨再生的当前治疗策略
Stem Cells Int. 2018 Mar 25;2018:8490489. doi: 10.1155/2018/8490489. eCollection 2018.